Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Hum Mol Genet ; 22(9): 1746-54, 2013 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-23359570

RESUMEN

Several known or putative glycosyltransferases are required for the synthesis of laminin-binding glycans on alpha-dystroglycan (αDG), including POMT1, POMT2, POMGnT1, LARGE, Fukutin, FKRP, ISPD and GTDC2. Mutations in these glycosyltransferase genes result in defective αDG glycosylation and reduced ligand binding by αDG causing a clinically heterogeneous group of congenital muscular dystrophies, commonly referred to as dystroglycanopathies. The most severe clinical form, Walker-Warburg syndrome (WWS), is characterized by congenital muscular dystrophy and severe neurological and ophthalmological defects. Here, we report two homozygous missense mutations in the ß-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) gene in a family affected with WWS. Functional studies confirmed the pathogenicity of the mutations. First, expression of wild-type but not mutant B3GNT1 in human prostate cancer (PC3) cells led to increased levels of αDG glycosylation. Second, morpholino knockdown of the zebrafish b3gnt1 orthologue caused characteristic muscular defects and reduced αDG glycosylation. These functional studies identify an important role of B3GNT1 in the synthesis of the uncharacterized laminin-binding glycan of αDG and implicate B3GNT1 as a novel causative gene for WWS.


Asunto(s)
Mutación Missense , N-Acetilglucosaminiltransferasas/genética , Síndrome de Walker-Warburg/genética , Animales , Línea Celular Tumoral , Mapeo Cromosómico , Estudios de Cohortes , Distroglicanos/metabolismo , Femenino , Regulación de la Expresión Génica , Técnicas de Silenciamiento del Gen , Glicosilación , Homocigoto , Humanos , Lactante , Laminina/metabolismo , Masculino , Distrofia Muscular de Cinturas/genética , N-Acetilglucosaminiltransferasas/metabolismo , Linaje , Fenotipo , Unión Proteica , Síndrome de Walker-Warburg/patología , Pez Cebra/genética
2.
Nat Genet ; 44(5): 581-5, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22522421

RESUMEN

Walker-Warburg syndrome (WWS) is an autosomal recessive multisystem disorder characterized by complex eye and brain abnormalities with congenital muscular dystrophy (CMD) and aberrant a-dystroglycan glycosylation. Here we report mutations in the ISPD gene (encoding isoprenoid synthase domain containing) as the second most common cause of WWS. Bacterial IspD is a nucleotidyl transferase belonging to a large glycosyltransferase family, but the role of the orthologous protein in chordates is obscure to date, as this phylum does not have the corresponding non-mevalonate isoprenoid biosynthesis pathway. Knockdown of ispd in zebrafish recapitulates the human WWS phenotype with hydrocephalus, reduced eye size, muscle degeneration and hypoglycosylated a-dystroglycan. These results implicate ISPD in a-dystroglycan glycosylation in maintaining sarcolemma integrity in vertebrates.


Asunto(s)
Distroglicanos/metabolismo , Mutación/genética , Síndrome de Walker-Warburg/genética , Pez Cebra/genética , Animales , Encéfalo/metabolismo , Encéfalo/patología , Preescolar , Embrión no Mamífero , Ojo/metabolismo , Ojo/patología , Glicosilación , Humanos , Manosiltransferasas/genética , Manosiltransferasas/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patología , Pez Cebra/embriología
3.
Am J Hum Genet ; 85(1): 76-86, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19576565

RESUMEN

Alpha-dystroglycanopathies such as Walker Warburg syndrome represent an important subgroup of the muscular dystrophies that have been related to defective O-mannosylation of alpha-dystroglycan. In many patients, the underlying genetic etiology remains unsolved. Isolated muscular dystrophy has not been described in the congenital disorders of glycosylation (CDG) caused by N-linked protein glycosylation defects. Here, we present a genetic N-glycosylation disorder with muscular dystrophy in the group of CDG type I. Extensive biochemical investigations revealed a strongly reduced dolichol-phosphate-mannose (Dol-P-Man) synthase activity. Sequencing of the three DPM subunits and complementation of DPM3-deficient CHO2.38 cells showed a pathogenic p.L85S missense mutation in the strongly conserved coiled-coil domain of DPM3 that tethers catalytic DPM1 to the ER membrane. Cotransfection experiments in CHO cells showed a reduced binding capacity of DPM3(L85S) for DPM1. Investigation of the four Dol-P-Man-dependent glycosylation pathways in the ER revealed strongly reduced O-mannosylation of alpha-dystroglycan in a muscle biopsy, thereby explaining the clinical phenotype of muscular dystrophy. This mild Dol-P-Man biosynthesis defect due to DPM3 mutations is a cause for alpha-dystroglycanopathy, thereby bridging the congenital disorders of glycosylation with the dystroglycanopathies.


Asunto(s)
Monofosfato de Dolicol Manosa/metabolismo , Manosiltransferasas/genética , Proteínas de la Membrana/genética , Distrofias Musculares/genética , Distrofias Musculares/metabolismo , Distroglicanos/metabolismo , Femenino , Glicosilación , Humanos
4.
Eur J Hum Genet ; 15(2): 155-61, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17106447

RESUMEN

The m.13513G > A transition in the mitochondrial gene encoding the ND5 subunit of respiratory chain complex I, can cause mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) and has been reported to be a frequent cause of Leigh syndrome (LS). We determined the frequency of the mutation in a cohort of 123 patients with reduced complex I activity in muscle (n = 113) or fibroblast (n = 10) tissue. We describe a Pyrosequencing assay for rapid detection and quantification of the m.13513G > A mutation. Two patients with the mutation were identified; both had LS, optical atrophy and a Wolff-Parkinson-White Syndrome (WPWS)-like cardiac conduction defect. The clinical presentation of the m.13513G > A mutation is discussed. We conclude that the m.13513G > A mutation seems not as frequent as previously suggested and is most likely to be present in patients with Leigh (-like) syndrome combined with a complex I deficiency, optic atrophy and/ or WPWS. In addition, we confirmed that the adjacent m.13514A > G mutation is a rare cause of LS or MELAS since no cases with this transition were found.


Asunto(s)
Complejo I de Transporte de Electrón/análisis , Enfermedad de Leigh/genética , Proteínas Mitocondriales/genética , Atrofia Óptica/genética , Síndrome de Wolff-Parkinson-White/genética , Estudios de Cohortes , Análisis Mutacional de ADN/métodos , ADN Mitocondrial/genética , Complejo I de Transporte de Electrón/genética , Femenino , Frecuencia de los Genes , Humanos , Enfermedad de Leigh/complicaciones , Enfermedad de Leigh/enzimología , Masculino , Músculo Esquelético/enzimología , Mutación , Atrofia Óptica/complicaciones , Atrofia Óptica/enzimología , Síndrome de Wolff-Parkinson-White/complicaciones , Síndrome de Wolff-Parkinson-White/enzimología
5.
Neuromuscul Disord ; 16(8): 510-3, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16919950

RESUMEN

Recognizing an ALS-mimic can be challenging. Here, we describe a patient with a slowly progressive dysarthria and dysphagia, with fasciculations of the tongue and general hyperreflexia, fulfilling the diagnostic criteria of 'clinical probable ALS'. Because of a non-conclusive EMG, a muscle biopsy was performed that surprisingly showed widespread nemaline rods. The clinical features and the histological findings were compatible with a sporadic late onset nemaline myopathy. Three years after initial presentation the patient died and post-mortem examination not only showed nemaline bodies in every muscle examined, but also revealed an unsuspected final diagnosis: sarcoid brainstem encephalitis. Nemaline rods can be found in various disorders, and neurosarcoidosis should be added to this list.


Asunto(s)
Tronco Encefálico/patología , Errores Diagnósticos/prevención & control , Encefalitis/complicaciones , Músculo Esquelético/patología , Miopatías Nemalínicas/complicaciones , Sarcoidosis/complicaciones , Esclerosis Amiotrófica Lateral/diagnóstico , Esclerosis Amiotrófica Lateral/fisiopatología , Biopsia , Tronco Encefálico/fisiopatología , Diagnóstico Diferencial , Encefalitis/diagnóstico , Encefalitis/fisiopatología , Resultado Fatal , Femenino , Granuloma/patología , Humanos , Cuerpos de Inclusión/metabolismo , Cuerpos de Inclusión/patología , Persona de Mediana Edad , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patología , Músculo Esquelético/fisiopatología , Miopatías Nemalínicas/diagnóstico , Miopatías Nemalínicas/fisiopatología , Neuronas/metabolismo , Neuronas/patología , Sarcoidosis/diagnóstico , Sarcoidosis/fisiopatología
6.
Hum Mutat ; 27(5): 453-9, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16575835

RESUMEN

The importance of O-glycosylation of alpha-dystroglycan (alpha-DG) is evident from the identification of POMT1 mutations in Walker-Warburg syndrome (WWS). Approximately one-fifth of the WWS patients show mutations in POMT1, which result in complete loss of protein mannosyltransferase activity. WWS patients are characterized by congenital muscular dystrophy (CMD) with severe brain and eye abnormalities. This suggests a crucial role for alpha-DG during development of these organs and tissues. Here we report new POMT1 mutations and polymorphisms in WWS patients. In addition, we report different compound heterozygous POMT1 mutations in four unrelated families that result in a less severe phenotype than WWS, characterized by CMD with calf hypertrophy, microcephaly, and mental retardation. Compared to WWS patients, these patients have milder structural brain abnormalities, and eye abnormalities were absent, except for myopia in some cases. In these patients we postulate that one or both transcripts for POMT1 confer residual protein O-mannosyltransferase activity. Our data suggest the existence of a disease spectrum of CMD including brain and eye abnormalities resulting from POMT1 mutations.


Asunto(s)
Discapacidad Intelectual/genética , Manosiltransferasas/genética , Microcefalia/genética , Distrofias Musculares/genética , Mutación , Adolescente , Encéfalo/anomalías , Encéfalo/patología , Preescolar , Mapeo Cromosómico , Análisis Mutacional de ADN , Distroglicanos/genética , Distroglicanos/metabolismo , Anomalías del Ojo/genética , Femenino , Humanos , Discapacidad Intelectual/diagnóstico , Discapacidad Intelectual/patología , Masculino , Manosiltransferasas/metabolismo , Microcefalia/diagnóstico , Microcefalia/patología , Repeticiones de Microsatélite , Distrofias Musculares/diagnóstico , Distrofias Musculares/patología , Fenotipo , Polimorfismo Genético , Síndrome
7.
J Virol Methods ; 117(2): 179-87, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15041215

RESUMEN

The potency of live attenuated virus vaccines is determined by counting or titrating viable viruses in cell cultures. These classical potency tests have the drawback that they are time consuming and laborious and show a high laboratory-to-laboratory variation. In the present study we describe the development and validation of a fast method to measure the potency of measles in trivalent measles, mumps and rubella (MMR) vaccines using quantitative real-time PCR (qPCR). Vero cells were infected with serial dilutions of a trivalent vaccine or a trivalent reference with known potency. Virus was allowed to replicate and subsequently replicated virus was quantitated by qPCR using the LightCycler technology. The virus titer in vaccine samples was estimated against reference preparations using parallel line analysis. In comparison to the plaque assay, the qPCR infectivity assay was faster and less laborious, while accuracy and intermediate precision were similar.


Asunto(s)
Vacuna Antisarampión/análisis , Virus del Sarampión/aislamiento & purificación , Animales , Chlorocebus aethiops , Virus del Sarampión/genética , Virus del Sarampión/fisiología , Reacción en Cadena de la Polimerasa/métodos , Reproducibilidad de los Resultados , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Células Vero , Ensayo de Placa Viral , Replicación Viral/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA